| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Apnea, Obstructive | 4 | 2013 | 142 | 1.140 |
Why?
|
| Cell Cycle Proteins | 4 | 2007 | 230 | 0.930 |
Why?
|
| DNA-Binding Proteins | 5 | 2007 | 700 | 0.850 |
Why?
|
| DNA Repair Enzymes | 3 | 2007 | 53 | 0.770 |
Why?
|
| Replication Protein A | 5 | 2007 | 9 | 0.740 |
Why?
|
| Cleft Palate | 2 | 2011 | 34 | 0.730 |
Why?
|
| Arterial Occlusive Diseases | 13 | 2010 | 134 | 0.720 |
Why?
|
| Polysomnography | 4 | 2014 | 92 | 0.700 |
Why?
|
| Nuclear Proteins | 3 | 2007 | 271 | 0.690 |
Why?
|
| Toes | 3 | 2010 | 27 | 0.660 |
Why?
|
| Brachial Artery | 4 | 2010 | 34 | 0.660 |
Why?
|
| Tracheostomy | 3 | 2014 | 31 | 0.620 |
Why?
|
| Vascular Surgical Procedures | 13 | 2017 | 168 | 0.600 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2007 | 24 | 0.590 |
Why?
|
| Peripheral Arterial Disease | 3 | 2017 | 83 | 0.580 |
Why?
|
| Ischemia | 10 | 2015 | 229 | 0.560 |
Why?
|
| Aortic Aneurysm, Abdominal | 7 | 2008 | 139 | 0.560 |
Why?
|
| Tonsillectomy | 3 | 2014 | 69 | 0.550 |
Why?
|
| Leg | 15 | 2004 | 191 | 0.510 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2013 | 32 | 0.470 |
Why?
|
| Continuous Positive Airway Pressure | 2 | 2013 | 33 | 0.460 |
Why?
|
| Adenoidectomy | 2 | 2013 | 51 | 0.460 |
Why?
|
| Blood Vessel Prosthesis | 14 | 2009 | 182 | 0.460 |
Why?
|
| Device Removal | 1 | 2014 | 100 | 0.450 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2013 | 12 | 0.450 |
Why?
|
| DNA Repair | 4 | 2007 | 127 | 0.430 |
Why?
|
| Hearing Disorders | 1 | 2012 | 23 | 0.400 |
Why?
|
| Otitis Media | 1 | 2012 | 35 | 0.400 |
Why?
|
| Eustachian Tube | 1 | 2012 | 31 | 0.390 |
Why?
|
| Hoarseness | 1 | 2011 | 6 | 0.380 |
Why?
|
| Ankle | 3 | 2010 | 45 | 0.380 |
Why?
|
| Femoral Artery | 9 | 2020 | 139 | 0.380 |
Why?
|
| Hearing | 1 | 2012 | 133 | 0.380 |
Why?
|
| Prosthesis-Related Infections | 3 | 2009 | 70 | 0.370 |
Why?
|
| Turbinates | 1 | 2010 | 12 | 0.370 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2011 | 40 | 0.370 |
Why?
|
| Nurse Clinicians | 1 | 2010 | 20 | 0.370 |
Why?
|
| Cleft Lip | 1 | 2011 | 33 | 0.360 |
Why?
|
| Retrospective Studies | 23 | 2020 | 7277 | 0.360 |
Why?
|
| Blood Loss, Surgical | 2 | 2010 | 79 | 0.360 |
Why?
|
| Severity of Illness Index | 6 | 2013 | 1851 | 0.360 |
Why?
|
| Humans | 79 | 2020 | 68618 | 0.360 |
Why?
|
| Male | 58 | 2020 | 37321 | 0.360 |
Why?
|
| Nasal Obstruction | 1 | 2010 | 34 | 0.360 |
Why?
|
| Nasal Mucosa | 1 | 2010 | 68 | 0.350 |
Why?
|
| Algorithms | 2 | 2015 | 1196 | 0.340 |
Why?
|
| DNA Damage | 3 | 2005 | 190 | 0.340 |
Why?
|
| Stents | 4 | 2002 | 657 | 0.340 |
Why?
|
| Popliteal Artery | 10 | 2015 | 40 | 0.340 |
Why?
|
| Endarterectomy, Carotid | 5 | 2011 | 110 | 0.340 |
Why?
|
| Vena Cava Filters | 2 | 2004 | 18 | 0.330 |
Why?
|
| Endovascular Procedures | 3 | 2020 | 366 | 0.330 |
Why?
|
| Aortic Rupture | 2 | 2008 | 32 | 0.290 |
Why?
|
| Female | 57 | 2020 | 38074 | 0.290 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2007 | 69 | 0.290 |
Why?
|
| Ultrasonography, Doppler | 1 | 2007 | 57 | 0.280 |
Why?
|
| DNA Replication | 2 | 2005 | 167 | 0.280 |
Why?
|
| Pulmonary Embolism | 2 | 2004 | 253 | 0.280 |
Why?
|
| Aortitis | 1 | 2006 | 5 | 0.280 |
Why?
|
| Clostridium septicum | 1 | 2006 | 5 | 0.280 |
Why?
|
| Child, Preschool | 6 | 2014 | 3187 | 0.270 |
Why?
|
| HeLa Cells | 5 | 2007 | 237 | 0.270 |
Why?
|
| Clostridium Infections | 1 | 2006 | 52 | 0.260 |
Why?
|
| Graft Occlusion, Vascular | 6 | 1998 | 73 | 0.260 |
Why?
|
| Vascular Patency | 10 | 2011 | 122 | 0.250 |
Why?
|
| Rhinitis | 1 | 2010 | 383 | 0.250 |
Why?
|
| Carotid Stenosis | 2 | 2011 | 163 | 0.240 |
Why?
|
| Aged | 40 | 2020 | 14862 | 0.240 |
Why?
|
| Lower Extremity | 3 | 2015 | 153 | 0.240 |
Why?
|
| Risk Factors | 17 | 2020 | 5731 | 0.240 |
Why?
|
| Decision Support Techniques | 3 | 2015 | 191 | 0.230 |
Why?
|
| Colonic Neoplasms | 1 | 2006 | 299 | 0.230 |
Why?
|
| Gastric Bypass | 1 | 2004 | 83 | 0.220 |
Why?
|
| Infant | 5 | 2013 | 2891 | 0.210 |
Why?
|
| Aged, 80 and over | 13 | 2020 | 4848 | 0.210 |
Why?
|
| Bacteroides Infections | 1 | 2002 | 3 | 0.210 |
Why?
|
| Etoposide | 3 | 2007 | 64 | 0.210 |
Why?
|
| Time Factors | 14 | 2020 | 4655 | 0.200 |
Why?
|
| MRE11 Homologue Protein | 3 | 2007 | 3 | 0.200 |
Why?
|
| Acid Anhydride Hydrolases | 3 | 2007 | 13 | 0.200 |
Why?
|
| Middle Aged | 34 | 2020 | 21147 | 0.200 |
Why?
|
| Treatment Outcome | 13 | 2020 | 7029 | 0.190 |
Why?
|
| Postoperative Complications | 10 | 2017 | 1615 | 0.190 |
Why?
|
| Cohort Studies | 3 | 2013 | 2358 | 0.190 |
Why?
|
| Angioscopy | 1 | 2001 | 1 | 0.190 |
Why?
|
| Follow-Up Studies | 9 | 2013 | 3259 | 0.180 |
Why?
|
| Peripheral Vascular Diseases | 4 | 2007 | 50 | 0.170 |
Why?
|
| Phosphorylation | 4 | 2007 | 1200 | 0.170 |
Why?
|
| Angioplasty, Balloon | 1 | 2000 | 110 | 0.170 |
Why?
|
| Catheterization, Peripheral | 1 | 2020 | 38 | 0.170 |
Why?
|
| Child | 7 | 2014 | 6405 | 0.170 |
Why?
|
| Photoplethysmography | 2 | 2010 | 15 | 0.160 |
Why?
|
| Blood Vessel Prosthesis Implantation | 5 | 2009 | 186 | 0.160 |
Why?
|
| Coronary Artery Bypass | 2 | 2011 | 218 | 0.160 |
Why?
|
| Aorta, Abdominal | 4 | 2007 | 97 | 0.160 |
Why?
|
| Risk Assessment | 5 | 2020 | 2007 | 0.150 |
Why?
|
| Comorbidity | 4 | 2015 | 1426 | 0.150 |
Why?
|
| Polytetrafluoroethylene | 6 | 2009 | 55 | 0.150 |
Why?
|
| Wound Healing | 1 | 2020 | 260 | 0.150 |
Why?
|
| Patient Discharge | 1 | 2020 | 294 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2013 | 2324 | 0.140 |
Why?
|
| Saphenous Vein | 7 | 2006 | 61 | 0.140 |
Why?
|
| Adult | 21 | 2020 | 21403 | 0.140 |
Why?
|
| Veins | 5 | 2011 | 68 | 0.140 |
Why?
|
| Thrombosis | 3 | 1998 | 218 | 0.140 |
Why?
|
| Hydroxyurea | 3 | 2005 | 57 | 0.130 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 136 | 0.130 |
Why?
|
| Gangrene | 1 | 1995 | 11 | 0.130 |
Why?
|
| Endoscopy | 2 | 2010 | 464 | 0.120 |
Why?
|
| Embolism | 3 | 2012 | 45 | 0.120 |
Why?
|
| Linear Models | 3 | 2017 | 521 | 0.120 |
Why?
|
| Medical Staff, Hospital | 1 | 2014 | 44 | 0.120 |
Why?
|
| Varicose Ulcer | 2 | 1993 | 42 | 0.120 |
Why?
|
| Ibuprofen | 1 | 2014 | 30 | 0.120 |
Why?
|
| Foot | 1 | 1995 | 66 | 0.120 |
Why?
|
| Cell Cycle | 2 | 2007 | 312 | 0.120 |
Why?
|
| Renal Dialysis | 2 | 2011 | 174 | 0.120 |
Why?
|
| General Surgery | 1 | 2014 | 95 | 0.110 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2014 | 45 | 0.110 |
Why?
|
| Coronary Artery Disease | 2 | 2011 | 696 | 0.110 |
Why?
|
| Age Distribution | 2 | 2013 | 320 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 261 | 0.110 |
Why?
|
| Otitis Media, Suppurative | 1 | 2013 | 4 | 0.110 |
Why?
|
| Acetaminophen | 1 | 2014 | 111 | 0.110 |
Why?
|
| Blood Gas Analysis | 1 | 2013 | 41 | 0.110 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2013 | 17 | 0.110 |
Why?
|
| Intervertebral Disc Degeneration | 1 | 2013 | 20 | 0.110 |
Why?
|
| Cell Nucleus | 2 | 2005 | 305 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2017 | 413 | 0.110 |
Why?
|
| Oxygen Consumption | 2 | 2013 | 258 | 0.110 |
Why?
|
| Monitoring, Physiologic | 2 | 2013 | 219 | 0.100 |
Why?
|
| Biopsy | 2 | 2013 | 540 | 0.100 |
Why?
|
| Chronic Disease | 3 | 2013 | 1330 | 0.100 |
Why?
|
| Intermittent Claudication | 5 | 1985 | 31 | 0.100 |
Why?
|
| Blood Flow Velocity | 2 | 1991 | 172 | 0.100 |
Why?
|
| Blotting, Western | 2 | 2005 | 954 | 0.100 |
Why?
|
| Age Factors | 3 | 2013 | 1864 | 0.100 |
Why?
|
| Pennsylvania | 1 | 2012 | 46 | 0.100 |
Why?
|
| Pain, Postoperative | 1 | 2014 | 214 | 0.100 |
Why?
|
| Sensitivity and Specificity | 5 | 2007 | 1753 | 0.100 |
Why?
|
| Iliac Artery | 3 | 1989 | 44 | 0.100 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2011 | 31 | 0.100 |
Why?
|
| Gastroesophageal Reflux | 2 | 2013 | 318 | 0.100 |
Why?
|
| Calcinosis | 1 | 2013 | 241 | 0.100 |
Why?
|
| Protein Binding | 2 | 2005 | 1027 | 0.100 |
Why?
|
| Pierre Robin Syndrome | 1 | 2011 | 7 | 0.100 |
Why?
|
| Velopharyngeal Insufficiency | 1 | 2011 | 14 | 0.090 |
Why?
|
| Nasal Decongestants | 1 | 2010 | 7 | 0.090 |
Why?
|
| Thrombectomy | 2 | 2012 | 238 | 0.090 |
Why?
|
| Ankle Brachial Index | 1 | 2010 | 10 | 0.090 |
Why?
|
| Aortic Diseases | 2 | 1989 | 113 | 0.090 |
Why?
|
| Administration, Topical | 1 | 2010 | 111 | 0.090 |
Why?
|
| Laryngoscopy | 1 | 2011 | 61 | 0.090 |
Why?
|
| Age of Onset | 1 | 2011 | 188 | 0.090 |
Why?
|
| Chi-Square Distribution | 4 | 2017 | 546 | 0.090 |
Why?
|
| Fibrinolytic Agents | 2 | 1991 | 377 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2013 | 622 | 0.090 |
Why?
|
| Models, Biological | 2 | 2005 | 981 | 0.090 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 60 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 1992 | 163 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2011 | 274 | 0.090 |
Why?
|
| Hospitals, University | 1 | 2010 | 169 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 1140 | 0.090 |
Why?
|
| Registries | 3 | 2017 | 733 | 0.090 |
Why?
|
| Odds Ratio | 4 | 2017 | 880 | 0.090 |
Why?
|
| Clinical Competence | 1 | 2014 | 657 | 0.090 |
Why?
|
| Lung Diseases, Obstructive | 1 | 1989 | 20 | 0.090 |
Why?
|
| Thrombolytic Therapy | 1 | 1991 | 233 | 0.080 |
Why?
|
| Carotid Body Tumor | 1 | 1989 | 4 | 0.080 |
Why?
|
| Life Tables | 5 | 1999 | 29 | 0.080 |
Why?
|
| Analgesics, Opioid | 1 | 2014 | 498 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2014 | 596 | 0.080 |
Why?
|
| South Carolina | 7 | 2011 | 2752 | 0.080 |
Why?
|
| Aneurysm | 3 | 1998 | 53 | 0.080 |
Why?
|
| Anticoagulants | 1 | 1991 | 356 | 0.080 |
Why?
|
| Incidence | 2 | 2012 | 1603 | 0.080 |
Why?
|
| Vascular Diseases | 2 | 2004 | 94 | 0.080 |
Why?
|
| Disease Progression | 1 | 2012 | 1038 | 0.080 |
Why?
|
| Blood Pressure Determination | 2 | 2007 | 152 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2010 | 340 | 0.080 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2008 | 178 | 0.080 |
Why?
|
| Markov Chains | 2 | 2007 | 133 | 0.080 |
Why?
|
| Aphidicolin | 1 | 2007 | 8 | 0.070 |
Why?
|
| Leupeptins | 1 | 2007 | 23 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2013 | 2223 | 0.070 |
Why?
|
| Wounds, Stab | 1 | 2007 | 7 | 0.070 |
Why?
|
| Proteasome Inhibitors | 1 | 2007 | 29 | 0.070 |
Why?
|
| Polyethylene Terephthalates | 4 | 1997 | 29 | 0.070 |
Why?
|
| Receptors, Thromboxane | 2 | 1998 | 122 | 0.070 |
Why?
|
| Ultraviolet Rays | 2 | 2005 | 130 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 1998 | 492 | 0.070 |
Why?
|
| Nursing Evaluation Research | 1 | 2007 | 46 | 0.070 |
Why?
|
| Hemorrhage | 1 | 1989 | 328 | 0.070 |
Why?
|
| Nursing Assessment | 1 | 2007 | 70 | 0.070 |
Why?
|
| Patient Care Team | 1 | 1989 | 311 | 0.070 |
Why?
|
| Bioprosthesis | 3 | 1983 | 101 | 0.070 |
Why?
|
| Abdominal Injuries | 1 | 2007 | 60 | 0.070 |
Why?
|
| Adolescent | 9 | 2011 | 8912 | 0.070 |
Why?
|
| Aneurysm, Infected | 1 | 2006 | 16 | 0.070 |
Why?
|
| Prevalence | 1 | 2011 | 1619 | 0.070 |
Why?
|
| Prognosis | 7 | 2001 | 2093 | 0.070 |
Why?
|
| Decision Trees | 3 | 2004 | 74 | 0.070 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2006 | 49 | 0.070 |
Why?
|
| Bias | 1 | 2007 | 148 | 0.070 |
Why?
|
| Colectomy | 1 | 2006 | 64 | 0.070 |
Why?
|
| Aneurysm, False | 1 | 2006 | 60 | 0.070 |
Why?
|
| Breast Neoplasms | 3 | 2001 | 1536 | 0.060 |
Why?
|
| Point-of-Care Systems | 1 | 2007 | 115 | 0.060 |
Why?
|
| Comet Assay | 1 | 2005 | 11 | 0.060 |
Why?
|
| DNA, Single-Stranded | 1 | 2005 | 41 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2005 | 99 | 0.060 |
Why?
|
| Mitomycin | 1 | 2005 | 27 | 0.060 |
Why?
|
| Camptothecin | 1 | 2005 | 39 | 0.060 |
Why?
|
| Cations | 1 | 2005 | 51 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 2077 | 0.060 |
Why?
|
| Macromolecular Substances | 1 | 2005 | 122 | 0.060 |
Why?
|
| Multiprotein Complexes | 1 | 2005 | 56 | 0.060 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2004 | 22 | 0.060 |
Why?
|
| G1 Phase | 1 | 2004 | 42 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 2279 | 0.060 |
Why?
|
| S Phase | 1 | 2004 | 38 | 0.060 |
Why?
|
| Precipitin Tests | 1 | 2004 | 88 | 0.060 |
Why?
|
| Immobilization | 1 | 2004 | 26 | 0.060 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 92 | 0.060 |
Why?
|
| Chromatin | 1 | 2004 | 76 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2004 | 155 | 0.060 |
Why?
|
| Umbilical Veins | 1 | 1983 | 54 | 0.060 |
Why?
|
| Lymph Nodes | 3 | 2001 | 258 | 0.060 |
Why?
|
| Fluoroscopy | 1 | 2004 | 152 | 0.050 |
Why?
|
| Arteriosclerosis | 3 | 1997 | 137 | 0.050 |
Why?
|
| Venous Thrombosis | 1 | 2004 | 125 | 0.050 |
Why?
|
| Length of Stay | 2 | 2004 | 780 | 0.050 |
Why?
|
| Limb Salvage | 2 | 2015 | 39 | 0.050 |
Why?
|
| Equipment Safety | 1 | 2002 | 50 | 0.050 |
Why?
|
| DNA | 1 | 2005 | 597 | 0.050 |
Why?
|
| Obesity, Morbid | 1 | 2004 | 172 | 0.050 |
Why?
|
| Anastomosis, Surgical | 4 | 2001 | 104 | 0.050 |
Why?
|
| Quality of Life | 2 | 2007 | 1515 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2004 | 378 | 0.050 |
Why?
|
| Lymphatic Metastasis | 2 | 2001 | 274 | 0.050 |
Why?
|
| Dobutamine | 2 | 1991 | 25 | 0.050 |
Why?
|
| Logistic Models | 2 | 2015 | 1420 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 1998 | 25 | 0.050 |
Why?
|
| Biomarkers, Tumor | 2 | 2001 | 508 | 0.040 |
Why?
|
| Punctures | 1 | 2020 | 35 | 0.040 |
Why?
|
| Carotid Arteries | 3 | 1997 | 110 | 0.040 |
Why?
|
| Emergencies | 1 | 2020 | 107 | 0.040 |
Why?
|
| Postoperative Care | 2 | 1991 | 163 | 0.040 |
Why?
|
| Multivariate Analysis | 3 | 2017 | 1046 | 0.040 |
Why?
|
| Coronary Disease | 2 | 1991 | 358 | 0.040 |
Why?
|
| Carotid Artery Diseases | 1 | 1999 | 83 | 0.040 |
Why?
|
| Thrombophlebitis | 2 | 1997 | 47 | 0.040 |
Why?
|
| Regional Blood Flow | 2 | 2012 | 168 | 0.040 |
Why?
|
| Pain | 3 | 1995 | 472 | 0.040 |
Why?
|
| Arteries | 3 | 2004 | 108 | 0.040 |
Why?
|
| Postoperative Hemorrhage | 2 | 2014 | 69 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 2001 | 365 | 0.040 |
Why?
|
| Receptors, Prostaglandin | 1 | 1998 | 74 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2000 | 403 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 792 | 0.040 |
Why?
|
| Diabetic Angiopathies | 1 | 1999 | 203 | 0.040 |
Why?
|
| Oxazoles | 1 | 1997 | 17 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2020 | 402 | 0.040 |
Why?
|
| Arthroplasty | 1 | 1997 | 24 | 0.040 |
Why?
|
| Total Quality Management | 1 | 1997 | 45 | 0.040 |
Why?
|
| Hospital Charges | 1 | 1997 | 60 | 0.040 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 1997 | 64 | 0.040 |
Why?
|
| Blood Platelets | 1 | 1998 | 284 | 0.030 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2008 | 130 | 0.030 |
Why?
|
| Thromboembolism | 3 | 1985 | 91 | 0.030 |
Why?
|
| Protamines | 1 | 1995 | 14 | 0.030 |
Why?
|
| Reoperation | 3 | 1996 | 467 | 0.030 |
Why?
|
| Ultrasonography | 3 | 1994 | 453 | 0.030 |
Why?
|
| Aspirin | 1 | 1997 | 295 | 0.030 |
Why?
|
| Carotid Artery Injuries | 2 | 1993 | 26 | 0.030 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 1995 | 22 | 0.030 |
Why?
|
| Angiography | 4 | 1998 | 194 | 0.030 |
Why?
|
| Angioplasty | 2 | 2007 | 118 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2017 | 384 | 0.030 |
Why?
|
| Hypertension, Renovascular | 1 | 1995 | 47 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1995 | 48 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 349 | 0.030 |
Why?
|
| Diabetes Complications | 2 | 1995 | 249 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 1465 | 0.030 |
Why?
|
| Dehydration | 1 | 2014 | 15 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1997 | 373 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 67 | 0.030 |
Why?
|
| Thallium Radioisotopes | 2 | 1991 | 13 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2000 | 1451 | 0.030 |
Why?
|
| United States | 2 | 2017 | 7367 | 0.030 |
Why?
|
| Survival Analysis | 1 | 1995 | 714 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2014 | 3705 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2014 | 328 | 0.030 |
Why?
|
| Epiglottis | 1 | 2013 | 11 | 0.030 |
Why?
|
| Postoperative Period | 2 | 2009 | 238 | 0.030 |
Why?
|
| Craniofacial Abnormalities | 1 | 2013 | 18 | 0.030 |
Why?
|
| Aortography | 2 | 2007 | 72 | 0.030 |
Why?
|
| Brain Concussion | 1 | 1993 | 27 | 0.030 |
Why?
|
| Craniocerebral Trauma | 1 | 1993 | 50 | 0.030 |
Why?
|
| Cervical Vertebrae | 1 | 2013 | 86 | 0.030 |
Why?
|
| Transplantation, Autologous | 2 | 2011 | 145 | 0.030 |
Why?
|
| Recurrence | 2 | 1993 | 948 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 649 | 0.030 |
Why?
|
| Up-Regulation | 1 | 1995 | 682 | 0.030 |
Why?
|
| Fasciotomy | 1 | 1992 | 12 | 0.030 |
Why?
|
| Hospitals, Military | 1 | 1992 | 13 | 0.030 |
Why?
|
| Groin | 1 | 1992 | 11 | 0.030 |
Why?
|
| Ligation | 1 | 1992 | 83 | 0.020 |
Why?
|
| Texas | 1 | 1992 | 92 | 0.020 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1993 | 131 | 0.020 |
Why?
|
| Down Syndrome | 1 | 2013 | 120 | 0.020 |
Why?
|
| Preoperative Care | 2 | 1991 | 275 | 0.020 |
Why?
|
| Equipment Design | 1 | 2012 | 500 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2005 | 1447 | 0.020 |
Why?
|
| Propensity Score | 1 | 2011 | 117 | 0.020 |
Why?
|
| Smoking | 2 | 1999 | 1452 | 0.020 |
Why?
|
| Graft Survival | 3 | 1998 | 465 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 1995 | 694 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 536 | 0.020 |
Why?
|
| Inguinal Canal | 1 | 2009 | 5 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 1989 | 123 | 0.020 |
Why?
|
| Hemostasis, Surgical | 1 | 1989 | 18 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1989 | 219 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 281 | 0.020 |
Why?
|
| Axilla | 2 | 1998 | 36 | 0.020 |
Why?
|
| Dogs | 1 | 1989 | 490 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2011 | 287 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2014 | 711 | 0.020 |
Why?
|
| Analysis of Variance | 3 | 2000 | 1040 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 1989 | 222 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2013 | 2455 | 0.020 |
Why?
|
| Embolization, Therapeutic | 1 | 1989 | 150 | 0.020 |
Why?
|
| Heart | 1 | 1991 | 850 | 0.020 |
Why?
|
| Locomotion | 1 | 2007 | 135 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 772 | 0.020 |
Why?
|
| Ulcer | 1 | 1985 | 27 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 1998 | 800 | 0.020 |
Why?
|
| Foot Diseases | 1 | 1985 | 20 | 0.020 |
Why?
|
| Phosphothreonine | 1 | 2005 | 5 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2005 | 14 | 0.020 |
Why?
|
| Rest | 1 | 1985 | 78 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 807 | 0.020 |
Why?
|
| Trypsin | 1 | 2005 | 64 | 0.020 |
Why?
|
| Aorta | 2 | 1986 | 316 | 0.020 |
Why?
|
| Arthroscopy | 1 | 1986 | 95 | 0.020 |
Why?
|
| Fistula | 1 | 1984 | 29 | 0.020 |
Why?
|
| Colonic Diseases | 1 | 1984 | 36 | 0.010 |
Why?
|
| Partial Pressure | 1 | 1984 | 19 | 0.010 |
Why?
|
| Patient Care Planning | 1 | 2004 | 108 | 0.010 |
Why?
|
| Swine | 2 | 1997 | 672 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2005 | 202 | 0.010 |
Why?
|
| Knee | 1 | 1983 | 17 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 1083 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2005 | 284 | 0.010 |
Why?
|
| Survival Rate | 2 | 1997 | 1056 | 0.010 |
Why?
|
| Catheterization | 1 | 1984 | 209 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2005 | 483 | 0.010 |
Why?
|
| Computer Systems | 1 | 2001 | 42 | 0.010 |
Why?
|
| Reference Standards | 1 | 2001 | 115 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2001 | 251 | 0.010 |
Why?
|
| DNA Primers | 1 | 2001 | 302 | 0.010 |
Why?
|
| Radionuclide Imaging | 2 | 1991 | 166 | 0.010 |
Why?
|
| Animals | 3 | 1997 | 20881 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2001 | 306 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 710 | 0.010 |
Why?
|
| Base Sequence | 1 | 2001 | 1015 | 0.010 |
Why?
|
| ROC Curve | 1 | 2000 | 392 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1999 | 193 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1998 | 11 | 0.010 |
Why?
|
| Mastectomy, Modified Radical | 1 | 1998 | 6 | 0.010 |
Why?
|
| Quality-Adjusted Life Years | 1 | 1999 | 106 | 0.010 |
Why?
|
| Breast Neoplasms, Male | 1 | 1998 | 12 | 0.010 |
Why?
|
| Keratins | 1 | 1998 | 48 | 0.010 |
Why?
|
| Blood Vessels | 1 | 1999 | 102 | 0.010 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 1998 | 41 | 0.010 |
Why?
|
| Prostaglandins H | 1 | 1998 | 32 | 0.010 |
Why?
|
| Mastectomy, Segmental | 1 | 1998 | 64 | 0.010 |
Why?
|
| Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 1998 | 48 | 0.010 |
Why?
|
| Stroke | 1 | 2011 | 2163 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 1998 | 127 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 1998 | 91 | 0.010 |
Why?
|
| Polyesters | 1 | 1998 | 55 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2001 | 1664 | 0.010 |
Why?
|
| Critical Pathways | 1 | 1997 | 33 | 0.010 |
Why?
|
| Tunica Intima | 1 | 1997 | 59 | 0.010 |
Why?
|
| Case Management | 1 | 1997 | 46 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 1998 | 504 | 0.010 |
Why?
|
| Hematocrit | 1 | 1995 | 70 | 0.010 |
Why?
|
| Hemostasis | 1 | 1995 | 32 | 0.010 |
Why?
|
| Sex Factors | 1 | 1999 | 1266 | 0.010 |
Why?
|
| Replantation | 1 | 1995 | 8 | 0.010 |
Why?
|
| Population Surveillance | 1 | 1997 | 285 | 0.010 |
Why?
|
| APACHE | 1 | 1995 | 41 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 1995 | 123 | 0.010 |
Why?
|
| Endarterectomy | 1 | 1995 | 22 | 0.010 |
Why?
|
| Heparin | 1 | 1995 | 205 | 0.010 |
Why?
|
| Creatinine | 1 | 1995 | 243 | 0.010 |
Why?
|
| Cause of Death | 1 | 1995 | 241 | 0.010 |
Why?
|
| Bandages, Hydrocolloid | 1 | 1993 | 3 | 0.010 |
Why?
|
| Colloids | 1 | 1993 | 43 | 0.010 |
Why?
|
| Zinc Oxide | 1 | 1993 | 18 | 0.010 |
Why?
|
| Carotid Artery, Common | 1 | 1993 | 25 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1997 | 1745 | 0.010 |
Why?
|
| Glycerol | 1 | 1993 | 26 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1995 | 1174 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1995 | 1738 | 0.010 |
Why?
|
| Myocardial Revascularization | 1 | 1990 | 56 | 0.010 |
Why?
|
| Hypertension | 1 | 1999 | 1535 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1991 | 601 | 0.010 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 1986 | 20 | 0.000 |
Why?
|
| Synovial Cyst | 1 | 1986 | 4 | 0.000 |
Why?
|
| Femoral Vein | 1 | 1985 | 15 | 0.000 |
Why?
|
| Streptokinase | 1 | 1985 | 23 | 0.000 |
Why?
|
| Injections, Intravenous | 1 | 1985 | 215 | 0.000 |
Why?
|
| Thromboangiitis Obliterans | 1 | 1985 | 2 | 0.000 |
Why?
|
| Arteritis | 1 | 1985 | 4 | 0.000 |
Why?
|
| Abscess | 1 | 1984 | 37 | 0.000 |
Why?
|
| Radiography | 1 | 1985 | 572 | 0.000 |
Why?
|
| Drainage | 1 | 1984 | 133 | 0.000 |
Why?
|
| Leg Ulcer | 1 | 1984 | 26 | 0.000 |
Why?
|
| Cardiac Catheterization | 1 | 1986 | 419 | 0.000 |
Why?
|
| Risk | 1 | 1983 | 563 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1982 | 705 | 0.000 |
Why?
|